Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2025)

Universe Pharmaceuticals has disclosed Long-Term Investments across 6 years of filings, most recently posting $702.3 million for Q3 2025.

• Long-Term Investments for Q3 2025 came in at $702.3 million, down 1.42% year-over-year; the trailing twelve-month figure through Sep 2025 was $702.3 million (down 1.42% YoY), and the FY2025 annual result was $702.3 million, down 1.42% from the prior year.
• Long-Term Investments came in at $702.3 million for Q3 2025 at Universe Pharmaceuticals, down from $712.5 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $712.5 million in Q3 2024 to a low of $586674.0 in Q1 2022.
• The 5-year median for Long-Term Investments is $736489.5 (2021), against an average of $265.1 million.
• Across the five-year window, Long-Term Investments sank 100.0% in 2021 and jumped 99822.61% in 2023, its largest moves.
• Universe Pharmaceuticals' Long-Term Investments stood at $744924.0 in 2021, then slipped by 5.64% to $702890.0 in 2022, then surged by 99822.61% to $702.3 million in 2023, then increased by 1.44% to $712.5 million in 2024, then declined by 1.42% to $702.3 million in 2025.
• The last three Long-Term Investments figures came in at $702.3 million (Q3 2025), $712.5 million (Q3 2024), and $692492.0 (Q1 2024), per Business Quant data.